Found: 114
Select item for more details and to access through your institution.
Inhibition of Cdk2 kinase activity selectively targets the CD44<sup>+</sup>/CD24<sup>-/Low</sup> stem-like subpopulation and restores chemosensitivity of SUM149PT triple-negative breast cancer cells.
- Published in:
- International Journal of Oncology, 2014, v. 45, n. 3, p. 1193, doi. 10.3892/ijo.2014.2523
- By:
- Publication type:
- Article
Vitamin D Levels, Vitamin D Receptor Polymorphisms, and Inflammatory Cytokines in Aromatase Inhibitor-Induced Arthralgias: An Analysis of CCTG MA.27.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Phase I Study of Panobinostat (LBH589) and Letrozole in Postmenopausal Metastatic Breast Cancer Patients.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Distinct spatial immune microlandscapes are independently associated with outcomes in triple-negative breast cancer.
- Published in:
- Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-37806-0
- By:
- Publication type:
- Article
Predicting the clinical outcomes and benefit from letrozole after 5 years of treatment with aromatase inhibitors for early breast cancer: analysis from CCTG MA.17R.
- Published in:
- Breast Cancer Research & Treatment, 2022, v. 191, n. 3, p. 523, doi. 10.1007/s10549-021-06448-5
- By:
- Publication type:
- Article
A clinical calculator to predict disease outcomes in women with triple-negative breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2021, v. 185, n. 3, p. 557, doi. 10.1007/s10549-020-06030-5
- By:
- Publication type:
- Article
Clinical evaluation of germline polymorphisms associated with capecitabine toxicity in breast cancer: TBCRC-015.
- Published in:
- Breast Cancer Research & Treatment, 2020, v. 181, n. 3, p. 623, doi. 10.1007/s10549-020-05603-8
- By:
- Publication type:
- Article
Optimized immunohistochemical detection of estrogen receptor beta using two validated monoclonal antibodies confirms its expression in normal and malignant breast tissues.
- Published in:
- Breast Cancer Research & Treatment, 2020, v. 179, n. 1, p. 241, doi. 10.1007/s10549-019-05441-3
- By:
- Publication type:
- Article
Metaplastic breast cancer has a poor response to neoadjuvant systemic therapy.
- Published in:
- Breast Cancer Research & Treatment, 2019, v. 176, n. 3, p. 709, doi. 10.1007/s10549-019-05264-2
- By:
- Publication type:
- Article
4-Hydroxytamoxifen enhances sensitivity of estrogen receptor α-positive breast cancer to docetaxel in an estrogen and ZNF423 SNP-dependent fashion.
- Published in:
- Breast Cancer Research & Treatment, 2019, v. 175, n. 3, p. 567, doi. 10.1007/s10549-019-05194-z
- By:
- Publication type:
- Article
Risk factors for bisphosphonate-associated osteonecrosis of the jaw in the prospective randomized trial of adjuvant bisphosphonates for early-stage breast cancer (SWOG 0307).
- Published in:
- Supportive Care in Cancer, 2021, v. 29, n. 5, p. 2509, doi. 10.1007/s00520-020-05748-8
- By:
- Publication type:
- Article
Pharmacogenomics of endocrine therapy in breast cancer.
- Published in:
- Journal of Human Genetics, 2013, v. 58, n. 6, p. 306, doi. 10.1038/jhg.2013.35
- By:
- Publication type:
- Article
Randomized clinical trial of CFP versus CMFP in women with metastatic breast cancer.
- Published in:
- 1989
- By:
- Publication type:
- journal article
Randomized trial to evaluate the addition of tamoxifen to cyclophosphamide, 5-fluorouracil, prednisone adjuvant therapy in premenopausal women with node-positive breast cancer.
- Published in:
- 1989
- By:
- Publication type:
- journal article
Additive hormonal therapy in women with advanced breast cancer.
- Published in:
- Cancer (0008543X), 1984, v. 53, n. S3, p. 766, doi. 10.1002/1097-0142(19840201)53:3+<766::AID-CNCR2820531327>3.0.CO;2-H
- By:
- Publication type:
- Article
Cis-diamminedichloroplatinum (II) administered by 24-hour infusion in the treatment of patients with advanced upper aerodigestive cancer.
- Published in:
- 1983
- By:
- Publication type:
- journal article
Phase II study of high-dose tamoxifen (NSC-180973) in patients with disseminated malignant melanoma.
- Published in:
- 1982
- By:
- Publication type:
- journal article
Chemotherapy for advanced head and neck cancer with the combination adriamycin, cyclophosphamide, and cis-diamminedichloroplatinum (II): preliminary assessment of a one-day vs. three-day drug regimen.
- Published in:
- 1981
- By:
- Publication type:
- journal article
Malignant, predominantly lymphocytic thymoma with central and peripheral nervous system metastases.
- Published in:
- 1981
- By:
- Publication type:
- journal article
Cyclophosphamide, adriamycin, and cis-diamminedichloroplatinum (II) in the treatment of patients with advanced head and neck cancer.
- Published in:
- 1981
- By:
- Publication type:
- journal article
Estrogen receptors in patients with malignant melanoma.
- Published in:
- 1980
- By:
- Publication type:
- journal article
A phase I study of chlorozotocin (NSC 178248).
- Published in:
- Cancer (0008543X), 1979, v. 43, n. 6, p. 2189, doi. 10.1002/1097-0142(197906)43:6<2189::AID-CNCR2820430605>3.0.CO;2-#
- By:
- Publication type:
- Article
SNPs near the cysteine proteinase cathepsin O gene (CTSO) determine tamoxifen sensitivity in ERα-positive breast cancer through regulation of BRCA1.
- Published in:
- PLoS Genetics, 2017, v. 13, n. 10, p. 1, doi. 10.1371/journal.pgen.1007031
- By:
- Publication type:
- Article
Utilizing Nottingham Prognostic Index in microarray gene expression profiling of breast carcinomas.
- Published in:
- Modern Pathology, 2004, v. 17, n. 7, p. 756, doi. 10.1038/modpathol.3800114
- By:
- Publication type:
- Article
Antitumor activity of Z-endoxifen in aromatase inhibitor-sensitive and aromatase inhibitor-resistant estrogen receptor-positive breast cancer.
- Published in:
- 2020
- By:
- Publication type:
- journal article
The Effects of a Novel Hormonal Breast Cancer Therapy, Endoxifen, on the Mouse Skeleton.
- Published in:
- PLoS ONE, 2014, v. 9, n. 5, p. 1, doi. 10.1371/journal.pone.0098219
- By:
- Publication type:
- Article
Aurora-A Mitotic Kinase Induces Endocrine Resistance through Down-Regulation of ERα Expression in Initially ERα+ Breast Cancer Cells.
- Published in:
- PLoS ONE, 2014, v. 9, n. 5, p. 1, doi. 10.1371/journal.pone.0096995
- By:
- Publication type:
- Article
Endoxifen's Molecular Mechanisms of Action Are Concentration Dependent and Different than That of Other Anti-Estrogens.
- Published in:
- PLoS ONE, 2013, v. 8, n. 1, p. 1, doi. 10.1371/journal.pone.0054613
- By:
- Publication type:
- Article
The bone marrow examination in breast cancer. Diagnostic considerations and clinical usefulness.
- Published in:
- Cancer (0008543X), 1978, v. 41, n. 2, p. 670, doi. 10.1002/1097-0142(197802)41:2<670::AID-CNCR2820410235>3.0.CO;2-V
- By:
- Publication type:
- Article
Bone marrow involvement in breast cancer: effect on response and tolerance to combination chemotherapy.
- Published in:
- 1977
- By:
- Publication type:
- journal article
Mediastinoscopy. A diagnostic aid in metastatic carcinoma of the breast.
- Published in:
- Cancer (0008543X), 1976, v. 37, n. 4, p. 1973, doi. 10.1002/1097-0142(197604)37:4<1973::AID-CNCR2820370449>3.0.CO;2-R
- By:
- Publication type:
- Article
Endocrine Therapy in 2009: Consideration of the Tumor and the Host.
- Published in:
- Oncology (08909091), 2009, v. 23, n. 2, p. 150
- By:
- Publication type:
- Article
Rcl is a novel ETV1/ER81 target gene upregulated in breast tumors.
- Published in:
- Journal of Cellular Biochemistry, 2008, v. 105, n. 3, p. 866, doi. 10.1002/jcb.21884
- By:
- Publication type:
- Article
Estrogen receptor α/β isoforms, but not βcx, modulate unique patterns of gene expression and cell proliferation in Hs578T cells.
- Published in:
- Journal of Cellular Biochemistry, 2007, v. 101, n. 5, p. 1125, doi. 10.1002/jcb.21205
- By:
- Publication type:
- Article
Identification of a broad coverage HLA-DR degenerate epitope pool derived from carcinoembryonic antigen.
- Published in:
- Cancer Immunology, Immunotherapy, 2010, v. 59, n. 1, p. 161, doi. 10.1007/s00262-009-0738-z
- By:
- Publication type:
- Article
Folate receptor alpha expression associates with improved disease-free survival in triple negative breast cancer patients.
- Published in:
- NPJ Breast Cancer, 2020, v. 6, n. 1, p. 1, doi. 10.1038/s41523-020-0147-1
- By:
- Publication type:
- Article
Breast cancer chemoprevention pharmacogenomics: Deep sequencing and functional genomics of the ZNF423 and CTSO genes.
- Published in:
- NPJ Breast Cancer, 2017, v. 3, n. 1, p. N.PAG, doi. 10.1038/s41523-017-0036-4
- By:
- Publication type:
- Article
Competing Causes of Death From a Randomized Trial of Extended Adjuvant Endocrine Therapy for Breast Cancer.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2008, v. 100, n. 4, p. 252, doi. 10.1093/jnci/djn014
- By:
- Publication type:
- Article
p27(Kip1) and cyclin E expression and breast cancer survival after treatment with adjuvant chemotherapy.
- Published in:
- 2006
- By:
- Publication type:
- journal article
p27<sup>Kip1</sup> and Cyclin E Expression and Breast Cancer Survival After Treatment With Adjuvant Chemotherapy.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2006, v. 98, n. 23, p. 1723, doi. 10.1093/jnci/djj467
- By:
- Publication type:
- Article
RESPONSE.
- Published in:
- 2006
- By:
- Publication type:
- Letter
Randomized Trial of Letrozole Following Tamoxifen as Extended Adjuvant Therapy in Receptor-Positive Breast Cancer: Updated Findings from NCIC CTG MA.17.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2005, v. 97, n. 17, p. 1262, doi. 10.1093/jnci/dji250
- By:
- Publication type:
- Article
Concordance between local and central laboratory HER2 testing in the breast intergroup trial N9831.
- Published in:
- 2002
- By:
- Publication type:
- journal article
Concordance Between Local Central Laboratory HER2 Testing in the Breast Intergroup Trial N9831.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2002, v. 94, n. 11, p. 855, doi. 10.1093/jnci/94.11.855
- By:
- Publication type:
- Article
Extended Adjuvant Endocrine Therapy in Breast Cancer: Current Status and Future Directions.
- Published in:
- Clinical Cancer Update, 2008, v. 2, n. 1, p. 11, doi. 10.3816/CCU.2008.n.003
- By:
- Publication type:
- Article
The lncRNA MIR2052HG regulates ERα levels and aromatase inhibitor resistance through LMTK3 by recruiting EGR1.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Calmodulin-like protein 3 is an estrogen receptor alpha coregulator for gene expression and drug response in a SNP, estrogen, and SERM-dependent fashion.
- Published in:
- 2017
- By:
- Publication type:
- journal article
A randomized trial of tamoxifen alone or combined with octreotide in the treatment of women with metastatic breast carcinoma.
- Published in:
- 1999
- By:
- Publication type:
- journal article
Molecular markers in male breast carcinoma.
- Published in:
- 1998
- By:
- Publication type:
- journal article
A randomized phase II trial of two dosage levels of letrozole as third-line hormonal therapy for women with metastatic breast carcinoma.
- Published in:
- 1997
- By:
- Publication type:
- journal article